{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:47:30Z","timestamp":1776905250031,"version":"3.51.2"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01474-0","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:35:40Z","timestamp":1773077740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patients"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6751-2110","authenticated-orcid":false,"given":"Pierre","family":"Bay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Boizeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8638-7183","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Pr\u00e9au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Favory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Guigon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Heming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3855-9304","authenticated-orcid":false,"given":"Elyanne","family":"Gault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-0711","authenticated-orcid":false,"given":"T\u00e0i","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Chaghouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Morand-Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lia","family":"Pitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Contou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-8185","authenticated-orcid":false,"given":"Amandine","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-4941","authenticated-orcid":false,"given":"Quentin","family":"Le Hingrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4884-8620","authenticated-orcid":false,"given":"Antoine","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Handala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Soulier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-7559","authenticated-orcid":false,"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-5006","authenticated-orcid":false,"given":"Christophe","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-4320","authenticated-orcid":false,"given":"Nicolas","family":"de Prost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slim","family":"Fourati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"1474_CR1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324, 782\u2013793 (2020).","journal-title":"JAMA"},{"key":"1474_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","volume":"47","author":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators","year":"2021","unstructured":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 47, 60\u201373 (2021).","journal-title":"Intensive Care Med."},{"key":"1474_CR3","doi-asserted-by":"crossref","unstructured":"Lamers M. M., Haagmans B. L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20, 270\u2013284 (2022).","DOI":"10.1038\/s41579-022-00713-0"},{"key":"1474_CR4","first-page":"162","volume":"21","author":"Carabelli","year":"2023","unstructured":"Carabelli et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol 21, 162\u2013177 (2023).","journal-title":"Nat. Rev. Microbiol"},{"key":"1474_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33801-z","volume":"13","author":"N de Prost","year":"2022","unstructured":"de Prost, N. et al. Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19. Nat. Commun. 13, 6025 (2022).","journal-title":"Nat. Commun."},{"key":"1474_CR6","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","volume":"370","author":"A Agarwal","year":"2020","unstructured":"Agarwal, A. et al. A living WHO guideline on drugs for covid-19. BMJ 370, m3379 (2020).","journal-title":"BMJ"},{"key":"1474_CR7","doi-asserted-by":"publisher","unstructured":"Bruse N., et al. Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients. Intensive Care Med [Internet]. 2024 Aug 26 [cited 2024 Sept 2]; Available from: https:\/\/doi.org\/10.1007\/s00134-024-07593-3.","DOI":"10.1007\/s00134-024-07593-3"},{"key":"1474_CR8","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1001\/jama.2021.5248","volume":"325","author":"K DeMerle","year":"2021","unstructured":"DeMerle, K., Angus, D. C. & Seymour, C. W. Precision medicine for COVID-19: phenotype anarchy or promise realized? JAMA 325, 2041\u20132042 (2021).","journal-title":"JAMA"},{"key":"1474_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha, P. et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am. J. Respir. Crit. Care Med 204, 1274\u20131285 (2021).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1474_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/infdis\/jiy608","volume":"219","author":"J Yu","year":"2019","unstructured":"Yu, J. et al. Host gene expression in nose and blood for the diagnosis of viral respiratory infection. J. Infect. Dis. 219, 1151\u20131161 (2019).","journal-title":"J. Infect. Dis."},{"key":"1474_CR11","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1164\/rccm.201602-0220OC","volume":"194","author":"WAA de Steenhuijsen Piters","year":"2016","unstructured":"de Steenhuijsen Piters, W. A. A. et al. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am. J. Respir. Crit. Care Med 194, 1104\u20131115 (2016).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1474_CR12","doi-asserted-by":"publisher","first-page":"e1009416","DOI":"10.1371\/journal.ppat.1009416","volume":"17","author":"C Rodriguez","year":"2021","unstructured":"Rodriguez, C. et al. Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19. PLoS Pathog. 17, e1009416 (2021).","journal-title":"PLoS Pathog."},{"key":"1474_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29268","volume":"95","author":"P Bay","year":"2023","unstructured":"Bay, P. et al. Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients. J. Med Virol. 95, e29268 (2023).","journal-title":"J. Med Virol."},{"key":"1474_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S1473-3099(21)00019-0","volume":"21","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2021","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez, B. et al. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect. Dis. 21, 783\u2013792 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"1474_CR15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S2213-2600(20)30366-0","volume":"8","author":"P Sinha","year":"2020","unstructured":"Sinha, P. et al. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. Lancet Respir. Med. 8, 1209\u20131218 (2020).","journal-title":"Lancet Respir. Med."},{"key":"1474_CR16","doi-asserted-by":"publisher","first-page":"2200592","DOI":"10.1183\/13993003.00592-2022","volume":"61","author":"C L\u00f3pez-Mart\u00ednez","year":"2023","unstructured":"L\u00f3pez-Mart\u00ednez, C. et al. Transcriptomic clustering of critically ill COVID-19 patients. Eur. Respir. J. 61, 2200592 (2023).","journal-title":"Eur. Respir. J."},{"key":"1474_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32573-w","volume":"13","author":"D Menges","year":"2022","unstructured":"Menges, D. et al. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort. Nat. Commun. 13, 4855 (2022).","journal-title":"Nat. Commun."},{"key":"1474_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med.27, 904\u2013916 (2021).","journal-title":"Nat. Med"},{"key":"1474_CR19","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","volume":"183","author":"Y Su","year":"2020","unstructured":"Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479\u20131495 (2020).","journal-title":"Cell"},{"key":"1474_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrg.2016.86","volume":"17","author":"EA Ashley","year":"2016","unstructured":"Ashley, E. A. Towards precision medicine. Nat. Rev. Genet 17, 507\u2013522 (2016).","journal-title":"Nat. Rev. Genet"},{"key":"1474_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood, K. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 173, 489\u2013495 (2005).","journal-title":"CMAJ"},{"key":"1474_CR22","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection","year":"2020","unstructured":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192\u2013e197 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"1474_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent, J. L. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707\u2013710 (1996).","journal-title":"Intensive Care Med."},{"key":"1474_CR24","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall, J. R., Lemeshow, S. & Saulnier, F. A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270, 2957\u20132963 (1993).","journal-title":"JAMA"},{"key":"1474_CR25","first-page":"2526","volume":"307","author":"Task ARDS Definition","year":"2012","unstructured":"ARDS Definition, T. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526\u20132533 (2012).","journal-title":"JAMA"},{"key":"1474_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/bjd.18611","volume":"183","author":"C Rodriguez","year":"2020","unstructured":"Rodriguez, C. et al. Pathogen identification by shotgun metagenomics of patients with necrotizing soft-tissue infections. Br. J. Dermatol 183, 105\u2013113 (2020).","journal-title":"Br. J. Dermatol"},{"key":"1474_CR27","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/nprot.2016.095","volume":"11","author":"M Pertea","year":"2016","unstructured":"Pertea, M., Kim, D., Pertea, G. M., Leek, J. T. & Salzberg, S. L. Transcript-level expression analysis of RNA-seq experiments with HISAT, stringtie and ballgown. Nat. Protoc. 11, 1650\u20131667 (2016).","journal-title":"Nat. Protoc."},{"key":"1474_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1474_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1910-1","volume":"20","author":"S Kovaka","year":"2019","unstructured":"Kovaka, S. et al. Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol. 20, 278 (2019).","journal-title":"Genome Biol."},{"key":"1474_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1474_CR31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s11121-015-0561-z","volume":"16","author":"D Henry","year":"2015","unstructured":"Henry, D., Dymnicki, A. B., Mohatt, N., Allen, J. & Kelly, J. G. Clustering methods with qualitative data: a mixed-methods approach for prevention research with small samples. Prev. Sci. 16, 1007\u20131016 (2015).","journal-title":"Prev. Sci."},{"key":"1474_CR32","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1474_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"1474_CR34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby, P. et al. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med"},{"key":"1474_CR35","doi-asserted-by":"crossref","unstructured":"Rosas I. O., et al. Tocilizumab in hospitalized patients with severe covid-19 pneumonia. N. Engl J. Med. 384, 1503\u20131516 (2021).","DOI":"10.1056\/NEJMoa2028700"},{"key":"1474_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03513-9","volume":"25","author":"Y Jouan","year":"2021","unstructured":"Jouan, Y., Baranek, T., Si-Tahar, M., Paget, C. & Guillon, A. Lung compartmentalization of inflammatory biomarkers in COVID-19-related ARDS. Crit. Care 25, 120 (2021).","journal-title":"Crit. Care"},{"key":"1474_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","volume":"23","author":"MS Diamond","year":"2022","unstructured":"Diamond, M. S. & Kanneganti, T. D. Innate immunity: the first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165\u2013176 (2022).","journal-title":"Nat. Immunol."},{"key":"1474_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"1474_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41590-021-00937-x","volume":"22","author":"M Zheng","year":"2021","unstructured":"Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol. 22, 829\u2013838 (2021).","journal-title":"Nat. Immunol."},{"key":"1474_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","volume":"6","author":"C Gabay","year":"2010","unstructured":"Gabay, C., Lamacchia, C. & Palmer, G. IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6, 232\u2013241 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1474_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s42003-021-01829-4","volume":"4","author":"BA Rosa","year":"2021","unstructured":"Rosa, B. A. et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun. Biol. 4, 290 (2021).","journal-title":"Commun. Biol."},{"key":"1474_CR42","doi-asserted-by":"crossref","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight [Internet]. 2020 June 4 [cited 2025 Jan 8];5(11). Available from: https:\/\/insight.jci.org\/articles\/view\/138999.","DOI":"10.1172\/jci.insight.138999"},{"key":"1474_CR43","unstructured":"Carmona-Rivera, C. et al. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19. JCI Insight [Internet]. 2022 Oct 5 [cited 2025 Jan 8];7(16). Available from: https:\/\/insight.jci.org\/articles\/view\/160332."},{"key":"1474_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","volume":"10","author":"RC Russo","year":"2014","unstructured":"Russo, R. C., Garcia, C. C., Teixeira, M. M. & Amaral, F. A. The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev. Clin. Immunol. 10, 593\u2013619 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"1474_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108448","volume":"169","author":"Y Huang","year":"2020","unstructured":"Huang, Y. et al. The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes. Diab. Res Clin. Pr. 169, 108448 (2020).","journal-title":"Diab. Res Clin. Pr."},{"key":"1474_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S2213-2600(22)00002-9","volume":"10","author":"JR Baker","year":"2022","unstructured":"Baker, J. R. et al. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.  Lancet Respiratory Med. 10, 545\u2013556 (2022).","journal-title":"Lancet Respiratory Med."},{"key":"1474_CR47","doi-asserted-by":"crossref","unstructured":"Donlan A. N., et al. IL-13 is a driver of COVID-19 severity. JCI Insight 6, e150107 (2021).","DOI":"10.1172\/jci.insight.150107"},{"key":"1474_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva, M. & O\u2019Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170\u2013181 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1474_CR49","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1164\/rccm.202005-1885OC","volume":"202","author":"S Hue","year":"2020","unstructured":"Hue, S. et al. Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med 202, 1509\u20131519 (2020).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"1474_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","volume":"42","author":"L Lu","year":"2021","unstructured":"Lu, L., Zhang, H., Dauphars, D. J. & He, Y. W. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 42, 3\u20135 (2021).","journal-title":"Trends Immunol."},{"key":"1474_CR51","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01256-23","volume":"11","author":"S Shahbaz","year":"2023","unstructured":"Shahbaz, S. et al. Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, delta variant, and omicron variant, identifies differential immune profiles. Microbiol. Spectr. 11, e01256-23 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1474_CR52","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1016\/j.cell.2023.08.026","volume":"186","author":"M Bouhaddou","year":"2023","unstructured":"Bouhaddou, M. et al. SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell 186, 4597\u20134614 (2023).","journal-title":"Cell"},{"key":"1474_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2023.199134","volume":"332","author":"G Gori Savellini","year":"2023","unstructured":"Gori Savellini, G., Anichini, G. & Cusi, M. G. SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells. Virus Res. 332, 199134 (2023).","journal-title":"Virus Res."},{"key":"1474_CR54","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/v14071583","volume":"14","author":"O Alfi","year":"2022","unstructured":"Alfi, O. et al. SARS-CoV-2 omicron induces enhanced mucosal interferon response compared to other variants of concern, associated with restricted replication in human lung tissues. Viruses 14, 1583 (2022).","journal-title":"Viruses"},{"key":"1474_CR55","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2548931","volume":"16","author":"N Rong","year":"2025","unstructured":"Rong, N. et al. Single-cell transcriptomic atlas of blood and lung from mice infected with SARS-CoV-2 revealing distinct virulence characteristics between prototype and Omicron BA.1 strain. Virulence 16, 2548931 (2025).","journal-title":"Virulence"},{"key":"1474_CR56","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.abn8939","volume":"377","author":"S Yuan","year":"2022","unstructured":"Yuan, S. et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 omicron in Syrian hamsters. Science 377, 428\u2013433 (2022).","journal-title":"Science"},{"key":"1474_CR57","doi-asserted-by":"publisher","first-page":"e0301330","DOI":"10.1371\/journal.pone.0301330","volume":"19","author":"PB Purwono","year":"2024","unstructured":"Purwono, P. B. et al. Infection kinetics, syncytia formation, and inflammatory biomarkers as predictive indicators for the pathogenicity of SARS-CoV-2 variants of concern in Calu-3 cells. PLOS ONE 19, e0301330 (2024).","journal-title":"PLOS ONE"},{"key":"1474_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04364-2","volume":"27","author":"TM Pelaia","year":"2023","unstructured":"Pelaia, T. M., Shojaei, M. & McLean, A. S. The role of transcriptomics in redefining critical illness. Crit. Care 27, 89 (2023).","journal-title":"Crit. Care"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01474-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01474-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:04:07Z","timestamp":1776902647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01474-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01474-0","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Slim Fourati reports having served as a speaker for Sanofi, GlaxoSmithKline, AstraZeneca, MSD, Pfeizer, Cepheid and Moderna. Jean-Michel Pawlotsky reports having served as an advisor and\/or speaker for Abbott, Abbvie, Diagnostics for the Real World, Gilead and GSK. Christophe Rodriguez reports having served as a speaker for Pfizer and Tecan. Nicolas de Prost reports having served as an advisor or speaker for Moderna and AstraZeneca. All other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Comit\u00e9 de Protection des Personnes Sud-M\u00e9diterran\u00e9e I (N\u00b0 EudraCT\/ID-RCB: 2021-A02914-37). Informed consent was obtained from all patients or their relatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics Approval And Consent To Participate"}}],"article-number":"238"}}